Bioventus
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · North Carolina, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
4721 Emperor Blvd Ste 100, Durham, North...Phone Number
(800) 396-4325Website
www.bioventus.comRevenue
$576.3 MillionStock Symbol
BVSIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
7
5
1
1
1
2
About Bioventus
Bioventus is a global leader of innovations for active healing. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products which address a growing need for clinically effective, cost efficient, minimally invasive medical treatments, that engage and enhance the bodys natural healing processes.Explore more
Bioventus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bioventus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Bioventus
Earning: See what the market has to say on Bioventus recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Bioventus has new funding data
Bioventus, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Bioventus has recently received funding, and reach out quickly before it becomes old news!
Check out if Bioventus is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Bioventus launches new products
Click to see if Bioventus had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Bioventus
Find 2 more new buyers
Compare Similar Companies to Bioventus
Compare insights from companies similar to Bioventus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bioventus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bioventus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bioventus.
Bioventus financials insights
Gather financial insights about Bioventus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$12M
2021
Stock Offering
$104M
Bioventus Tech Stack
A closer look at the technologies used by Bioventus
See more technologies
Most Recent Scoops
Open Position
Earnings
Bioventus has reported Q1 revenue growth of 5% year-over-year in its Global Restorative Therapies segment, with the company continuing to expect mid-single digit revenue growth for the full year.
Earnings, Finance
Earnings
Bioventus has reported Q1 adjusted operating income of $20 million, an increase of nearly $3 million compared to the prior year, and adjusted net income of $13 million, an increase of $7 million year-over-year, driven by revenue growth, improved gross margin, and lower interest expense.
Earnings, Finance
Earnings
Bioventus has reported Q1 cash flow from operations of $9 million, an increase of more than $28 million compared to Q1 of the prior year and the largest Q1 cash flow from operations since the company became public, driven by higher profitability, lower interest expense, and favorable working capital, ending the quarter with $36 million in cash and $272 million in outstanding debt, a reduction of $22 million during the quarter. The company plans to continue prioritizing debt repayment and expects its net leverage ratio to fall below 2x by the end of Q2 2026, ahead of schedule.
Earnings, Business Finance, Finance, Financing & Debt
Earnings
Earnings, Accounting, Financial Reporting, Finance
Bioventus News & Media
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026, at 4:00 p.m. ET.Bioventus Inc. (BVS) Q1 2026 Earnings Call Transcript
Bioventus Inc. (BVS) Q1 2026 Earnings Call May 6, 2026 8:30 AM EDTCompany ParticipantsDavid Crawford - Vice President of Investor Relations &...Bioventus Reports First Quarter Financial Results
DURHAM, N.C., May 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the three months ended March 28, 2026.Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2026 before the market opens on Wednesday, May 6, 2026. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bioventus
Sign Up For FreeTo access detailed company insights
Bioventus is a global leader of innovations for active healing. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products which address a growing need for clinically effective, cost efficient, minimally invasive medical treatments, that engage and enhance the b... Read More
